Publication Name	World Journal of Gastrointestinal Endoscopy
Manuscript ID	94520
Country	Spain

Received	2024-03-19 19:42
Peer-Review Started	2024-03-19 19:42
To Make the First Decision
Return for Revision	2024-04-08 20:12
Revised	2024-04-10 15:41
Second Decision	2024-04-29 03:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-04-29 06:37
Articles in Press	2024-04-29 06:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-09 02:09
Publish the Manuscript Online	2024-05-14 02:49

ISSN	1948-5190 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Has Coca-Cola treatment become the first-line therapy for gastric bezoars, both in general and specifically for western countries?
Manuscript Source	Invited Manuscript
All Author List	Maria Delgado Galan and Luis Ramon Rabago
Funding Agency and Grant Number
Corresponding Author	Luis Ramon Rabago, MD, PhD, Chief Physician, Department of Gastroenterology, Hospital San Rafael, Street Serrano 199 , Madrid 28016, Spain. lrabagot@gmail.com
Key Words	Phytobezoars; Endoscopic treatment; Oral dissolution treatment with Coca-Cola; Randomized study; Editorial
Core Tip	The study by Liu et al, is a prospective randomized study about the treatment of gastric phytobezoars through daily intake of Coca-Cola vs endoscopic treatment, and represents an important step in clinical research on this topic. Given the promising outcomes of the Coca-Cola treatment observed in this study, which demonstrated a 100% success rate in dissolving phytobezoars and showed reduced costs and occurrence of gastric ulcers, it is recommended as a primary treatment option for phytobezoars. The study's exclusions, such as patients with upper gastric surgery, phytobezoars older than 14 d, and cases of gastroparesis, limit its applicability to broader populations, especially in Western countries.
Publish Date	2024-05-14 02:49
Citation	<p>Delgado Galan M, Rabago LR. Has Coca-Cola treatment become the first-line therapy for gastric bezoars, both in general and specifically for western countries? <i>World J Gastrointest Endosc</i> 2024; 16(5): 237-243</p>
URL	https://www.wjgnet.com/1948-5190/full/v16/i5/237.htm
DOI	https://dx.doi.org/10.4253/wjge.v16.i5.237

Full Article (PDF)	WJGE-16-237-with-cover.pdf
Manuscript File	94520_Auto_Edited-YJP.docx
Answering Reviewers	94520-Answering reviewers.pdf
Audio Core Tip	94520-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	94520-Conflict-of-interest statement.pdf
Copyright License Agreement	94520-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	94520-Language certificate.pdf
Peer-review Report	94520-Peer-review(s).pdf
Scientific Misconduct Check	94520-Bing-Liu H-2.png
Scientific Editor Work List	94520-Scientific editor work list.pdf
CrossCheck Report	94520-CrossCheck report.pdf